Founder and Managing Director, BioMed Ventures
Bruce is the founder and Managing Director of BioMed Ventures and serves on the leadership team of BioMed Realty. He maintains extensive relationships with leading institutional investors, world-class entrepreneurs, and top executives developed over eighteen years of investing and operating in the biotech sector. Bruce was Chief Executive Officer and co-founder of Rincon Pharmaceuticals from 2004 until its acquisition in 2008; previously he was Chief Business Officer at Anaphore and Head of Corporate Development at Ambit Biosciences. Bruce received his Bachelor of Arts degree from Dartmouth College, his Masters of Business Administration degree from the Marshall School of Business at the University of Southern California, and he holds the designation of Chartered Financial Analyst. Bruce served as or is a Board Observer or Member at the following life science companies: Aegea, Amplyx, Anaptys, Auspex, Breathe, CardioFocus, Celula, Compass, Edge, Genalyte, Histogenics, Laguna, NanoString, NeuroVia, OptiScan, Pathwork, Promedior, Receptos, Suneva, Tracon, and Zosano.